Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(5 sites)

China

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

Deqing People'S Hospital, Huzhou

Ningbo No.2 Hospital, Ningbo